Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$477.41 USD

477.41
2,104,200

+15.02 (3.25%)

Updated Aug 12, 2025 04:00 PM ET

After-Market: $477.56 +0.15 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (147 out of 245)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Zacks Equity Research

Here's Why You Should Invest in West Pharmaceutical (WST) Now

by Zacks Equity Research

West Pharmaceutical (WST) continues to gain momentum on the back of strength in the Proprietary Products business.

Zacks Equity Research

Medtronic (MDT) Businesses Rebound Amid Raging Pandemic

by Zacks Equity Research

Medtronic (MDT) is registering strong organic growth in the Cardiovascular, Neuroscience and Diabetes segments on product launches.

Zacks Equity Research

Bruker (BRKR) Introduces JPK NanoWizard V for AFM Research

by Zacks Equity Research

Bruker's (BRKR) newly-introduced JPK NanoWizard V is expected to significantly contribute to life science atomic force microscopy investigations.

Zacks Equity Research

Edwards Lifesciences' (EW) SAPIEN 3 With Alterra Gets FDA Nod

by Zacks Equity Research

Edwards Lifesciences' (EW) SAPIEN 3 system with Alterra adaptive prestent is indicated for use in the management of pediatric and adult patients with severe pulmonary regurgitation.

Zacks Equity Research

Here's Why You Should Retain DexCom (DXCM) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Zacks Equity Research

Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

by Zacks Equity Research

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

Zacks Equity Research

Accuray's (ARAY) CyberKnife System Gets Shonin Approval

by Zacks Equity Research

Accuray's (ARAY) CyberKnife System can now be marketed in Japan post the Shonin approval.

Zacks Equity Research

Is Thermo Fisher Scientific (TMO) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Thermo Fisher Scientific (TMO) and West Pharmaceutical Services (WST) have performed compared to their sector so far this year.

Zacks Equity Research

Here's Why You Should Hold on to Alcon (ALC) Stock for Now

by Zacks Equity Research

Investors are optimistic about Alcon's (ALC) better-than-expected third-quarter results and robust performance by the Vision Care arm.

Zacks Equity Research

Here's Why You Should Retain Haemonetics (HAE) Stocks for Now

by Zacks Equity Research

Investors are optimistic about Haemonetics (HAE) on a strong recovery across businesses, mainly at Hospital, and the initial Plasma Persona rollouts.

Zacks Equity Research

Medtronic's (MDT) INVOS System Gets FDA 510 (k) Clearance

by Zacks Equity Research

Medtronic's (MDT) INVOS 7100 system can deliver key signals to pediatric clinicians for making time-sensitive decisions

Zacks Equity Research

Avantor (AVTR) to Improve Biopharma Supply Chain With New Site

by Zacks Equity Research

Avantor's (AVTR) new logistics hub in Westminster is intended to support growth of single-use businesses.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Thermo Fisher Scientific, Salesforce, Nike and Texas Instruments

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Thermo Fisher Scientific, Salesforce, Nike and Texas Instruments

Zacks Equity Research

Here's Why You Should Retain Catalent (CTLT) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Catalent (CTLT) owing to its robust facility expansion activities and a slew of strategic deals.

Mark Vickery headshot

Top Research Reports for Berkshire Hathaway, Thermo Fisher & salesforce

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Thermo Fisher Scientific Inc. (TMO), and salesforce.com, inc. (CRM).

Zacks Equity Research

Here's Why You Should Hold on to NEOGEN (NEOG) Stock for Now

by Zacks Equity Research

Investors are optimistic about NEOGEN (NEOG) given robust sales growth in the Food Safety business and impressive international performance.

Zacks Equity Research

Here's Why You Should Retain STERIS (STE) Stock for Now

by Zacks Equity Research

Investors are optimistic about STERIS (STE) owing to strong segmental growth and bullish 2022 outlook.

Zacks Equity Research

Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Thermo Fisher Scientific (TMO) closed at $661.25, marking a +0.84% move from the previous day.

Zacks Equity Research

FDA Approves Intuitive Surgical's (ISRG) Latest SureForm Stapler

by Zacks Equity Research

Intuitive Surgical's (ISRG) newest stapler is expected to result in better surgical outcomes.

Zacks Equity Research

NEOGEN (NEOG) Gains on 3M's Food Safety Arm Merger Deal

by Zacks Equity Research

According to NEOGEN (NEOG), apart from the United States and Europe, substantial interest among developing nations to improve food safety presents significant growth potential for the combined company.

Zacks Equity Research

Walgreens (WBA), Village MD Plan to Expand Into San Antonio

by Zacks Equity Research

Walgreens (WBA) and VillageMD to improve access to overall care for patients with chronic conditions by opening nine new Village Medical at Walgreens primary care practices in San Antonio.

Zacks Equity Research

Zacks Industry Outlook Highlights: Thermo Fisher Scientific, STERIS and Accuray

by Zacks Equity Research

Zacks Industry Outlook Highlights: Thermo Fisher Scientific, STERIS and Accuray

Zacks Equity Research

Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FLQL

Zacks Equity Research

Veeva's (VEEV) Data Cloud to Aid PharmaEssentia's New Product

by Zacks Equity Research

Adoption of Veeva Systems' (VEEV) cloud applications is likely to significantly boost its Commercial Cloud business.

Urmimala Biswas headshot

3 Top Medical Instruments Stocks to Counter Industry Headwinds

by Urmimala Biswas

The Zacks Medical - Instruments industry is growing on COVID-support business gains. TMO, STE and ARAY are set to gain the most. Yet, demand for base business is on the decline with the new COVID variant disrupting the trend.